Here are the latest quarterly results of Biocon. For more details, see the Biocon financial fact sheet and Biocon share price and chart. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-19* |
3
Jun-19* |
3
Sep-19* |
3
Dec-19* |
3
Mar-20* |
3
Jun-20* |
3
Sep-20* |
3
Dec-20* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 7,639 | 4,808 | 15,722 | 17,481 | 15,810 | 16,713 | 17,448 | 18,510 | |
Other income | Rs m | 139 | 253 | 384 | 358 | 631 | 183 | 155 | 279 | |
Turnover | Rs m | 7,778 | 5,061 | 16,106 | 17,839 | 16,441 | 16,896 | 17,603 | 18,789 | |
Expenses | Rs m | 6,654 | 4,074 | 11,694 | 13,039 | 12,624 | 12,580 | 13,534 | 14,515 | |
Gross profit | Rs m | 985 | 1,554 | 4,703 | 4,442 | 3,186 | 4,133 | 3,914 | 3,995 | |
Depreciation | Rs m | 375 | 240 | 1,316 | 1,440 | 1,524 | 1,668 | 1,777 | 1,863 | |
Interest | Rs m | 6 | 5 | 138 | 177 | 168 | 125 | 65 | 48 | |
Profit before tax | Rs m | 743 | 1,562 | 3,633 | 3,183 | 2,125 | 2,523 | 2,227 | 2,363 | |
Tax | Rs m | 38 | 342 | 1,001 | 848 | 450 | 809 | 223 | 489 | |
Profit after tax | Rs m | 705 | 1,220 | 2,632 | 2,335 | 1,675 | 1,714 | 2,004 | 1,874 | |
Gross profit margin | % | 12.9 | 32.3 | 29.9 | 25.4 | 20.2 | 24.7 | 22.4 | 21.6 | |
Effective tax rate | % | 5.1 | 21.9 | 27.6 | 26.6 | 21.2 | 32.1 | 10.0 | 20.7 | |
Net profit margin | % | 9.2 | 25.4 | 16.7 | 13.4 | 10.6 | 10.3 | 11.5 | 10.1 | |
Diluted EPS | Rs | 1.2 | 2.0 | 4.4 | 3.9 | 2.8 | 2.9 | 3.3 | 3.1 | |
Diluted EPS (TTM) | Rs | 13.6 | 13.4 | 11.4 | 11.5 | 13.1 | 13.9 | 12.9 | 12.1 | |
![]() |
Read: Biocon 3QFY21 Result Performance Review
More Pharmaceuticals Company Quarterly Results: CIPLA AMAR REMEDIES TTK HEALTHCARE FDC ASTRAZENECA PHARMA
Compare BIOCON With: CIPLA AMAR REMEDIES TTK HEALTHCARE FDC ASTRAZENECA PHARMA
Compare BIOCON With: MYLAN (US) ACTAVIS (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
Share markets in India are presently trading marginally lower. The BSE Sensex is trading down by 160 points, down 0.3% at 50,685 levels.
For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.
For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.
More Views on NewsLast time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
In this video, I'll show you how to get started on the path to daily trading profits.
An Indian company founded three decades ago in a garage caught my attention...
In this video, I'll show you how to allocate your capital as a day trader.
More